Life Sciences MVP: O'Melveny's Paul Scrivano

Law360, New York (December 4, 2012, 5:20 PM EST) -- O'Melveny & Myers LLP partner Paul Scrivano has a broad mergers and acquisitions practice, but it is his work on cross-border deals involving the cutting edge of the biotech industry and an innovative investment in a Georgia firm that earned him a spot on Law360's list of Life Sciences MVPs.

Stretching back to October 2011, Scrivano has been involved in a string of major deals in the life sciences field, including representing Chinese orthopedic implant maker China Kanghui Holdings as it negotiated an $816 million buyout...
To view the full article, register now.